NCT01914432

Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

A Double-blind, Randomized, Multi-center Phase III Clinical Trial to Investigate the Safety and Efficacy Between YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 210 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

To evaluate efficacy and safety of YH16410 versus rosuvastatin and telmisartan monotherapies in patients with hypertension and hyperlipidemia

Conditions

• Hyperlipidemia
• Hypertension

Interventions

Type	Name	Description
DRUG	YH16410
DRUG	Rosuvastatin
DRUG	Telmisartan
DRUG	YH16410 placebo
DRUG	Rosuvastatin placebo
DRUG	Telmisartan placebo

Timeline

• Start date: 2013-11-01
• Primary completion: 2014-06-01
• Completion: 2014-06-01
• First posted: 2013-08-02
• Last updated: 2014-07-08

Locations

1 site across 1 country: South Korea